Cancer / Oncology
Telix Advances Development of Glioblastoma Therapy Program
TLX101 (4-L-[131I] iodo-phenylalanine, or 131I-IPA) is one of the Company's lead therapeutic clinical programs and has been granted orphan drug design...
March 23, 2022 | News
Gene Solutions Makes Earlier Detection of Cancer A Possibility of the Future
Globally, cancer causes one in six deaths with more than 21 million people developing annually. 70% of cancers in patients are detected at late stages in w...
March 16, 2022 | News
China NMPA Approves Tislelizumab for Patients with Microsatellite Instability-High or Mismatch Repair-Deficient Solid Tumors
-BeiGene, Ltd. , a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and...
March 14, 2022 | News
Biobot Surgical signs MOU with BEBIG Medical to collaborate on a robotic-guided prostate brachytherapy solution
Biobot Surgical developed the iSR'obot Mona Lisa 2.0, a robotic-assisted percutaneous surgical system that allows clinicians to plan and position...
March 14, 2022 | News
Arctoris and Evariste Technologies form a Joint Venture to Identify Novel Small Molecule cMET Inhibitors for Non-Small Cell Lung Cancer
Arctoris, a tech-enabled biopharma company, and Evariste Technologies, an AI-drug discovery company, today announced they have formed a joint venture to id...
March 08, 2022 | News
SeekIn Receives CE Mark Approval for SeekInCare® Pan Cancer Early Detection Test
SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, today announced the CE (Conformité Européenne) Mark f...
February 25, 2022 | News
Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China
JAB-21822 in combination with cetuximab for the treatment of KRAS G12C-mutated advanced colorectal cancer. Colorectal cancer is the second most common tumo...
February 24, 2022 | News
Patients can now benefit from same-day procedure to diagnose and treat lung cancer
Imagine being diagnosed with lung cancer and having the tumor surgically removed on the same day, thereby increasing the opportunity for limited follow-up ...
February 22, 2022 | News
First Proton Therapy Treatment Delivered in Southeast Asia
The Varian ProBeam uses sophisticated imaging to see, adapt, and deliver treatment to the designated site, using a powerful particle accelerator called the...
February 09, 2022 | News
mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN
New research in the February 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine ...
February 08, 2022 | News
LISCure Biosciences Announces Research Collaboration with The Scripps Research Institute for Immuno-Oncology
Scripps Research is the top nonprofit scientific institute in the US for producing high-quality research based on discoveries published in leading scientif...
February 04, 2022 | News
Reaction Biology Announces Integrated Drug Discovery Solution
The Reaction Oncology Platform is based on a network of strategic partners, including oncology and biophysics by the US and Germany-based Reaction Biology,...
February 03, 2022 | News
BioMed X Institute and Merck KGaA, Extend Collaboration in Oncology
German independent research institute BioMed X announces today the extension of its collaboration with Merck KGaA, Darmstadt, Germany, in the res...
February 01, 2022 | News
Debiopharm and Aspen Partner to launch prostate cancer drug trelstar® in South Africa
In 2020, nearly 14,000 South African men were newly diagnosed with prostate cancer1 with an average of 5 men dying from the disease every day.2 I...
February 01, 2022 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
